Why the study?
Does bariatric and metabolic surgery improve lipid profiles in patients with severe obesity?
Population
123 patients with severe obesity, mean age 48.2 ± 7.9 years, 25.2% male, mean BMI 47.0 ± 9.1 kg/m2
Design
Cohort
Follow-up
16.9 ± 8.1 months
Key result
Bariatric and metabolic surgery, particularly Roux-en-Y gastric bypass, significantly reduced triglyceride, LDL, and non-HDL cholesterol levels over a mean follow-up of 16.9 months.
Authors
Loading...
Lipid improvements after bariatric surgery should not yet change practice; leaves open randomized CV outcome trials.
Observational (n=123)
No
Does bariatric and metabolic surgery improve lipid profiles in patients with severe obesity?
Bariatric and metabolic surgery, particularly Roux-en-Y gastric bypass, significantly improves lipid profiles in patients with severe obesity, contributing to cardiovascular risk reduction.
Greco et al. (2022) conducted an observational in Severe obesity (n=123). Bariatric and metabolic surgery (sleeve gastrectomy and Roux-en-Y gastric bypass) was evaluated on Change in total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) cholesterol, and triglycerides. Bariatric and metabolic surgery, particularly Roux-en-Y gastric bypass, significantly reduced triglyceride, LDL, and non-HDL cholesterol levels over a mean follow-up of 16.9 months.